AKT1 and cancer: Therefore, the development of specific inhibitors to attenuate advanced autophagy processes mediated by ERK and Akt, consequently quelling the expression of autophagy-related genes, presents a promising avenue for combating drug-resistant cancers influenced by HIF-1α-induced autophagy.